InspireMDNSPR
About: InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Employees: 68
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
45% more capital invested
Capital invested by funds: $24.3M [Q1] → $35.1M (+$10.9M) [Q2]
12.43% more ownership
Funds ownership: 43.93% [Q1] → 56.36% (+12.43%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
14% less funds holding
Funds holding: 28 [Q1] → 24 (-4) [Q2]
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Piper Sandler Adam Maeder 56% 1-year accuracy 9 / 16 met price target | 89%upside $4.50 | Overweight Reiterated | 17 Sept 2024 |
Financial journalist opinion
Based on 4 articles about NSPR published over the past 30 days
